DaVita Inc. DVA

Updated: 8 Sep 2026

NYSE | Healthcare and kidney care

No signal published yet

We already track DaVita and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow DaVita free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NYSE
Sector
Healthcare and kidney care
We're already tracking DaVita Inc. — here are the latest events we've registered

Recent News

  • On August 25, 2026, DaVita announced a new value-based partnership with Humana to expand care for more than 10,000 Medicare Advantage members with chronic kidney disease. The agreement utilizes DaVita Integrated Kidney Care's coordinated care model to help delay or prevent dialysis and reduce hospitalizations.

What Firelda Watch includes for DaVita Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of DaVita Inc. will be delivered in the same format.

Want to follow DaVita Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow DaVita free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

DaVita Inc. DVA
DaVita — follow and we'll monitor it
Follow DaVita free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.